Search or choose
Find the right test or package.
AML ETO t(8;21), Quantitative
The (8;21) translocation identifies a subgroup of Acute Myeloid Leukemia (AML) with a relatively good prognosis which may require a different treatment. It is usually associated with the AML subtype M2. Detection of t(8;21) has diagnostic, prognostic & therape...
DiagnosticsLab test
Know more about this test
The (8;21) translocation identifies a subgroup of Acute Myeloid Leukemia (AML) with a relatively good prognosis which may require a different treatment. It is usually associated with the AML subtype M2. Detection of t(8;21) has diagnostic, prognostic...
Understanding AML ETO t(8;21), Quantitative
The (8;21) translocation identifies a subgroup of Acute Myeloid Leukemia (AML) with a relatively good prognosis which may require a different treatment. It is usually associated with the AML subtype M2. Detection of t(8;21) has diagnostic, prognostic & therapeutic implications for the patient.
What does AML ETO t(8;21), Quantitative measure?
The (8;21) translocation identifies a subgroup of Acute Myeloid Leukemia (AML) with a relatively good prognosis which may require a different treatment. It is usually associated with the AML subtype M2. Detection of t(8;21) has diagnostic, prognostic & therapeutic implications for the patient.
Related parameters
How does home sample collection work?
Select slot
Pick a convenient time.
Phlebotomist visit
A trained expert arrives home.
Safe testing
Samples move through the lab process.
Digital reports
Reports are delivered online.